Magnus Brändén
Profile
Magnus Brändén worked as Director of Research & Development at Layerlab AB and as Principal at the Royal Institute of Technology.
He holds a doctorate degree from the University of Stockholm.
Former positions of Magnus Brändén
| Companies | Position | End |
|---|---|---|
| Royal Institute of Technology | Corporate Officer/Principal | - |
Layerlab AB
 Layerlab AB Pharmaceuticals: MajorHealth Technology Layerlab AB is a supplier of lipid membrane immobilization technology for protein analyses, in particular for use in drug discovery. It will primarily supply commercial and academic researchers with immobilization kits for various applications, such as protein interaction studies using biosensors or assembly of protein arrays. Layerlab is aiming to support drug researchers and developers by supplying enabling immobilization technologies for the analysis of membrane bound and associated biomolecules in biosensor instruments. The company was founded in 2002 and is headquartered in Göteborg, Sweden. | Chief Tech/Sci/R&D Officer | - |
Training of Magnus Brändén
| University of Stockholm | Doctorate Degree |
Experiences
Positions held
Linked companies
| Private companies | 1 |
|---|---|
Layerlab AB
Layerlab AB Pharmaceuticals: MajorHealth Technology Layerlab AB is a supplier of lipid membrane immobilization technology for protein analyses, in particular for use in drug discovery. It will primarily supply commercial and academic researchers with immobilization kits for various applications, such as protein interaction studies using biosensors or assembly of protein arrays. Layerlab is aiming to support drug researchers and developers by supplying enabling immobilization technologies for the analysis of membrane bound and associated biomolecules in biosensor instruments. The company was founded in 2002 and is headquartered in Göteborg, Sweden. | Health Technology |
- Stock Market
- Insiders
- Magnus Brändén
